Apprendre à traduire à partir d'exemples de traductions humaines.
De: Traduction automatique
Suggérer une meilleure traduction
Qualité :
Réalisées par des traducteurs professionnels, des entreprises, des pages web ou traductions disponibles gratuitement.
mergrangvaxtarheilkenni / brátt kyrningahvítblæði
myelodysplastic syndrome / acute myeloid leukaemia
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
sjúklingar með kyrningahvítblæði eða mergrangvaxtarheilkenni
patients with myeloid leukaemia or myelodysplastic syndromes
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
sérstaklega getur verið aukin hætta á beinsarkmeini, mergrangvaxtarheilkenni og hvítblæði.
in particular, the risk for osteosarcoma, myelodysplastic syndrome and leukaemias may be increased.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
greint hefur verið frá mergrangvaxtarheilkenni / bráðu kyrningahvítblæði hjá ellefu af 211 sjúklingum sem fengu zevalin meðferð.
myelodysplastic syndrome (mds)/ acute myeloid leukaemia (aml) has been reported in eleven out of 211 patients assigned to treatment with zevalin.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
endurteknar blóðgjafir geta verið nauðsynlegar sjúklingum með ýmsar tegundir blóðleysis (til dæmis dvergkornablóðleysi, sigðkornablóðleysi eða mergrangvaxtarheilkenni).
repeated blood transfusions may be necessary in patients with various types of anaemia (for example thalassaemia, sickle cell disease or myelodysplastic syndromes (mds)).
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
Öryggi og verkun lonquex hafa ekki verið rannsökuð hjá sjúklingum með langvinnt kyrningahvítblæði, mergrangvaxtarheilkenni eða síðkomið brátt kyrningahvítblæði; því skal ekki nota það handa þessum sjúklingum.
the safety and efficacy of lonquex have not been investigated in patients with chronic myeloid leukaemia, myelodysplastic syndromes or secondary acute myeloid leukaemia; it should therefore not be used in such patients.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
til þess að draga úr lengd daufkyrningafæðar og tíðni daufkyrningafæðar ásamt hita hjá fullorðnum sjúklingum sem fá meðferð með frumudrepandi krabbameinslyfjum við illkynja sjúkdómum (að frátöldu langvinnu kyrningahvítblæði og mergrangvaxtarheilkenni).
reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
hjá örfáum sjúklingum hefur verið greint frá mergrangvaxtarheilkenni/bráðu mergfrumuhvítblæði (mds/aml) sem fengu lynpraza eingöngu eða samhliða öðrum krabbameinslyfjum; flest tilvikin reyndust banvæn.
myelodysplastic syndrome/acute myeloid leukaemia (mds/aml) have been reported in a small number of patients who received lynparza alone or in combination with other anti-cancer drugs; the majority of cases have been fatal.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :